Searched for
MOLNUPIRAVIR CAPSULE TRIAL
Molnupiravir reduced Covid-linked hospitalisation by over 65%: StudyThe Phase III trial results of Hetero's Movfor (Molnupiravir), presented at the Conference on Retroviruses and Opportunistic Infections (CR...- Phase III trials of COVID drug Movfor show positive results, says HeteroThe results, presented as an Oral Abstract at the Conference on Retroviruses and Opportunistic Infections (CROI) held virtually February 12...
- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
- Dr Reddy's launches molnupiravir at Rs 35 per pill, matching Mankind's priceDr. Reddy’s Molflu will be priced at Rs. 35 per capsule with 10 capsules contained per strip, and the total course of 40 capsules over 5 da...
- A full Molnupiravir treatment likely to cost up to Rs 3,000The recommended dose of molnupiravir is 800 mg twice a day for five days. With companies planning to launch 200 mg capsules, a patient will...
- Pharma stocks gain as DGCI approves emergency use of COVID pill MolnupiravirShares of Strides Pharma were up 2.3 per cent while those of Cipla gained 1.4 per cent. Dr Reddy’s scrip registered a gain of close to a pe...
- Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...
- Natco Pharma plans to launch Molnupiravir capsules this week for treatment of COVID-19Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection ...
- Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortlyThe drug firm said it is able to manufacture the active pharmaceutical ingredient (API) as well as the formulation for Molnupiravir, and ha...
- Hetero gets DCGI nod to manufacture, market Molnupiravir capsulesUnder the licensing deal, Hetero will be allowed to expand access of Molnupiravir in India and in other low-and middle-income countries, fo...
- Cipla to launch Molnupiravir under Cipmolnu brand name for COVID-19 treatment"This launch is yet another step in our endeavour to enable access to all treatments in COVID care. We continue to be guided by the power o...
- Companies race to make COVID antiviral drug molnupiravir available in pharmaciesDrug maker Cipla said it will soon make molnupiravir capsules available at all leading pharmacies and Covid treatment centers across the co...
- COVID-19: Corbevax, Covovax, Molnupiravir approved for emergency useUnion Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- Government panel recommends EUA for COVID-19 vaccines Covovax, Corbevax and anti-Covid pill molnupiravirThe SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...
- MSN Lab initiates Phase III clinical trial of Molnupiravir capsules for COVID-19 treatmentThe company said it has received its clinical trial approval on May 19, 2021, from the Drug Controller General of India (DCGI) to perform a...
- Natco Pharma shares hit upper circuit. Here's whyThe Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.
- Natco initiates phase-3 clinical trials of Molnupiravir capsules for COVID-19 treatmentNatco Pharma on Friday said it has initiated phase-III clinical trials of Molnupiravir capsules to evaluate its efficacy in treating patien...
- Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in IndiaMolnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-Co...
- Natco seeks emergency nod for Molnupiravir to treat CovidThe development comes close on the heels of findings announced by the researchers that Molnupiravir was found effective for treating the pa...
Load More
